EDF Health

Lead pipe survey flaws reveal that states may not be getting their fair share

An estimated 9.2 million homes and buildings in the nation get their drinking water through a lead pipe, according to EPA’s April 2023 report. The agency estimated the number of lead service lines (LSLs) in each state to arrive at the country’s total.[1]

Based on these estimates, each state was allocated a share of the almost $3 billion in state revolving fund (SRF) resources dedicated to LSL replacement in the current federal fiscal year (FY23). As explained in EDF’s blog about EPA’s announcement, two states had surprisingly high numbers: Florida with 1.2 million LSLs and Texas with 650,000.

To better understand the driving force behind the estimates, we dug into a dataset containing the majority of utility and state responses to the LSL portion of the EPA survey. This data is readily available because of a Freedom of Information Act (FOIA) submission by the Natural Resources Defense Council seeking the survey responses.[2]

First impressions

With some exceptions that we’ll address in a moment, the LSL estimates reported by states and utilities were consistent with our expectations.[3] However, we also came across significant discrepancies in three key states that prompted us to investigate further.

Overall, there are three distinct problems that need untangling and warrant attention more broadly: data entry errors, conflicting state and utility information, and inconsistent directions by the state.

To its credit, EPA recognized these issues as well and plans to offer states and utilities an opportunity to revise their survey responses this fall. Those responses will then be used to allocate the remaining $9 billion dedicated to LSL replacement in FY24, FY25, and FY26. Based on what we found for Florida and Texas alone, we may have roughly 1.6 million fewer LSLs than originally estimated – good news overall.

About EPA’s survey

Every four years, EPA conducts a voluntary survey to estimate the nation’s drinking water infrastructure needs and allocate funding provided by Congress to address these needs. In 2021, EPA conducted the 7th Drinking Water Infrastructure Needs Survey & Assessment (DWINSA), which for the first time ever included information on LSLs.[4]

EPA reports that about 75% of large and medium utilities responded to the LSL portion of the survey. State agencies coordinated collection and submission of the information to the EPA. Because of the FOIA response, we have access to what EPA described as “raw, unadjusted LSL Inventory data uploaded to the [DWINSA] Website as of October 25, 2022.”[5]

As explained in the agency’s FAQs, EPA calculated the estimated number of LSLs in each state based on the sum of two components: the number of reported LSLs and the number of “undiscovered service lines [that] might be lead”.

Texas: Data entry errors

EPA’s report placed Texas and its estimated 647,640 LSLs within the top five states with the most LSLs. Based on this, the agency allocated $146 million in FY23 to assist Texas water utilities in replacing the seemingly large number of LSLs.

However, of the 116 large and medium-sized Texas utilities included in the dataset, only three reported having lead pipes in their system.[6] By far, the City of Houston led the group at 302,359 LSLs, a figure that would have earned the number two spot among all cities across the country. The other two Texas utilities – Fort Worth and Bryan – reported less than 1,000 lead pipes each.

We contacted Houston to verify their number. They promptly explained that there was a data entry error: 302,359 should have been entered as “service lines for which the material makeup of the service line and of the connector are not known”. They added that a recent reevaluation of their data would decrease the number of service lines of an unknown material to 274,098.

With this new information and our understanding of EPA’s calculation, we estimate that Texas most likely has less than 100,000 LSLs.[7] If this is correct, the state’s allocation in FY24-26 should be reduced from $146 million to the baseline of $28 million that is allocated to any state regardless of its number of LSLs. The change would free up $118 million for other states in those fiscal years.

We do not know how many other utilities may have had similar data entry errors, but all utilities should doublecheck their survey responses when EPA provides the opportunity in the fall of 2023. We expect many utilities will have improved their estimates in preparation for the October 2024 deadline to submit service line material inventories to their state under the revised Lead and Copper Rule.

Florida: Conflicting state and utility information

Florida became the state with the most LSLs when EPA estimated it to have 1,159,300 of these pipes replacing Illinois. Based on this, EPA allocated almost $255 million LSL replacement funding to Florida in FY23. Shocked by this news, we had to find out if Florida truly deserved its newfound number one spot.

Pinellas County Utilities appeared at the top of the list of Florida utilities in EPA’s dataset[8] with 40,380 LSLs. When we reached out to the utility, they told us they reported all of their service lines as “unknown” and shared a copy of the spreadsheet they submitted to the state that confirmed this. If the number of LSLs reported in EPA’s dataset for Pinellas County was accurate, that meant almost one-third of their total service lines are lead pipes, a much higher rate than cities with a long history of LSLs.

The question remained whether there was a broader trend at play with Florida’s numbers. This prompted us to reach out to the five other large utilities that reported more than 20,000 LSLs. These utilities serve Jacksonville, Fort Lauderdale, Cocoa, Hillsborough County, and Pasco County.

We heard back from all but one and the sentiment was the same – confusion as to where the numbers in EPA’s dataset came from. Some stated that they are just now starting to inventory their service lines ahead of the October 2024 deadline, and others don’t remember responding to any survey at all. We contacted Florida DEP, the agency that oversees drinking water programs, but have not heard back.

At this stage, it is still unclear as to where the numbers for individual utilities in Florida originated, but we suspect that the state provided them. As such, we estimate that there are less than 100,000 LSLs in Florida.[9] If this is correct, its allocation for LSL replacement should be reduced from $255 million to the $28 million baseline allocation.

Ultimately, what the utilities reported to the state conflicts with what showed up in EPA’s dataset. EPA and the state should work together to figure it out. Based on the lesson learned, EPA should identify states where similar problems may have occurred.

New York: Inconsistent directions

EPA estimated that New York State has 494,007 LSLs, bringing in almost $114 million for LSL replacement in FY23.

Out of the 59 medium and large utilities[10] in New York listed in EPA’s dataset, 19 reported LSLs in their distribution area.[11] We were surprised to find that New York City was listed as “no lines reported” even though their service line material data was publicly available at the time of the survey.[12]

When asked about why they didn’t report LSLs to EPA, New York City’s water utility staff responded that they were told by the state not to provide it. The state’s SRF program manager confirmed that New York City’s LSL data was not requested so New York City could focus its efforts on getting several large infrastructure projects included in the base survey, explaining that these efforts resulted in the second largest DWINSA need increase nationally. He also noted that New York City was the only public utility they did not engage with on the LSL portion of the survey.

Based on our understanding of how EPA calculated a state’s number of LSLs and how large New York City is compared to other cities in the state, we think that EPA’s estimate for New York State may be low.[13] However, in our follow-up communications with the state, we were told that EPA’s calculations includes estimates for New York City because it is based on data for other medium and large utilities in the state. The city provided a similar message. Until we see EPA’s formula in more detail, we cannot know for sure.

Nonetheless, we encourage the state and New York City to update their reporting and to provide an opportunity for other utilities to update their DWINSA responses.

Summary

We thank NRDC for submitting the FOIA request and EPA for making it publicly available. The information allowed us to look more closely at the surprises in EPA’s LSL estimates.

We also applaud EPA for its willingness to give states and utilities the opportunity to update the LSL information. We anticipate that this will enable a fairer allocation of the funding dedicated to LSL replacement to states based on their need.

We recognize that the problems found here may not be unusual for any survey seeking previously undisclosed information, especially since some of the parties did not understand that the information would affect each state’s share of the $15 billion in funding dedicated to LSL replacement.

 

 

[1] EPA’s estimate of 9.2 million LSLs includes service lines that are classified as “galvanized requiring replacement” but excludes 2.8 million standalone galvanized pipes. See page 6 of the EPA’s 7th DWINSA Fact Sheet for service line category definitions.

[2] We focused on the last file uploaded by EPA on November 7, 2022 named “EPA-2022-003617 Responsive Document Batch 6” and tab labelled “State Med-Large Data”.

[3] Based on a 2016 American Water Works Association (AWWA) Survey of LSL estimates.

[4] In 2017, Congress directed EPA to collect information on LSLs as part of the DWINSA in America’s Water Infrastructure Act (AWIA) of 2018 (P.L. 115-270).

[5] See file from FOIA response named “EPA-2022-003617 Responsive Document Batch 6” and tab labelled “Data Caveats”.

[6] EPA assigned each utility’s response (see Column E: Status) to one of four categories. Out of the 116 large and medium sized Texas utilities in the dataset, 59 utilities reported 0 lines. The remaining reported at least 1 line under the following categories: 4 all unknown, 37 no unknown, 16 some unknown.

[7] EPA’s estimate of 647,620 LSLs in Texas means that 5% of all of the service lines in the state are lead. If the number drops to less than 100,000, that translates to only 0.7% of all service lines in the state being made of lead.

[8] EPA assigned each utility’s response (see Column E: Status) to one of four categories. Out of the 85 large and medium Florida utilities in the dataset, 18 utilities reported 0 lines. The remaining reported at least 1 line under the following categories: 1 all unknown, 4 no unknown, 63 some unknown.

[9] EPA’s estimate of 1,159,300 LSLs in Florida means that 17% of all of the service lines in the state are lead. If the number drops to less than 100,000, that translates to only 1.5% of all service lines in the state being made of lead.

[10] New York State told us that 5 of the 59 utilities were removed from the state’s sample after the DWINSA data collection began.

[11] EPA assigned each utility’s response (see Column E: Status) to one of four categories. Out of the 59 large and medium-sized New York utilities in the dataset, 15 utilities reported 0 lines. The remaining reported at least 1 line under the following categories: 11 all unknown, 18 no unknown, 17 some unknown.

[12] In 2021, EDF downloaded New York City’s service line inventory from their OpenData website, showing 62,770 potential lead service lines and 126,395 service lines of unknown material. New York City told us in a June 2023 email that it reported 137,542 potential LSLs and 230,870 service lines of unknown material in 2021.

[13] EPA’s estimate of 494,007 LSLs in New York means that 14% of all of the service lines in the state are lead. If the number increases by at least 100,000 to include New York City, that translates to 17% of all service lines in the state being made of lead.

Posted in Deep Dives, Lead / Authors: / Comments are closed

Flaws found in EPA’s lead pipe survey of states and water utilities

Deep Dive: Read our Deep Dives blog for an in-depth analysis on the data that drove the 2023 allocation of federal funding for lead service line replacements.

What’s New: EPA recently estimated there are 9.2 million lead service lines (LSLs) in the nation’s drinking water infrastructure based on information reported by states and water utilities. This was collected as part of a survey conducted every four years to understand drinking water infrastructure needs.

The agency estimated the number of LSLs for each state. Two had surprisingly high numbers: Florida with 1.2 million LSLs and Texas with 650,000.

After reviewing data EPA used to estimate each state’s totals[1], we believe that these two may have less than 100,000 LSLs each. If true, this means the country may actually have about 1.6 million fewer LSLs than originally thought – good news overall.

Read More »

Posted in Deep Dives, Drinking water, Lead / Tagged , , , , | Authors: , / Comments are closed

FDA’s squishy definition of adverse health effects of substances in food

Maricel Maffini, consultant, and Tom Neltner, Senior Director, Safer Chemicals

3 human figures showing stages of becoming ill. First figure is all white and standing up straight. Second figure is bent over and stomach area is red. Third figure is is all red, bent over, and appears to be vomiting.

What Happened

A recent peer-reviewed publication criticized FDA’s criteria for identifying adverse health effects associated with exposure to pathogens, chemicals, or allergens in foods. The authors gave two recent examples of the agency dismissing health concerns: a toxin created in spoiled fish that caused temporary, medically adverse health effects because they were short-term and reversible, and an additive where evidence from animal testing showed harm in only one sex. The authors concluded that the agency’s criteria are “inadequate because they are not science-based.”

Why It Matters

FDA is responsible for protecting food safety and the public’s health. In order to do that, it makes decisions whether a pathogen, chemical, or allergen causes an adverse health effect that must be avoided—so the agency’s definition of an adverse health effect is critically important. Unfortunately, FDA lacks a clear definition of the term, usually approaching it on a case-by-case basis in a manner that lacks transparency and scientific grounding.

Adverse Effects Dismissed by FDA

In 2020, the director of The Pew Charitable Trusts’ food safety project argued that FDA failed to “protect Americans from preventable illnesses” because it considered that the effects caused by the fish toxin were temporary or reversible. FDA described the toxin’s effects, which ranged from facial flushing and sweating, dizziness, nausea and headache to more severe cases of blurred vision, respiratory stress, and swelling of the tongue. The Pew director reasonably added that people may require hospitalization, medical treatment due to cardiac complications, and altered blood pressure–all of which are adverse health effects.

In a 2019 final rule approving the listing of leghemoglobin as a color additive, the Center for Food Safety objected that FDA dismissed statistically significant “changes in blood chemistry, blood clotting ability, and blood globulin values” as potential health effects. In its response to the objection, the agency argued that “statistical differences seen between control animals and treatment animals due to small changes in the value of the parameter are not likely to be of biological or toxicological significance.” FDA further stated that for the color additive to cause the blood changes to be “potentially adverse” it should:

  • Show a “clear dose-response,” described as a direct relationship between the dose given and the effect observed, in other words, the higher the dose, the higher the effect; and
  • Be observed in both sexes of the species in which the substance is tested.

This argument put forth by FDA’s food safety scientists would be summarily dismissed by their colleagues on the drug side because it ignores current scientific principles: dose responses can have different shapes and there are known sex differences in response to exposures from multiple chemicals.

Our Take

This is an ongoing issue. Other organizations have defined “adverse health effects.” For example, EPA’s Integrated Risk Information System (IRIS) defines adverse effect as “[a] biochemical change, functional impairment, or pathologic lesion that affects the performance of the whole organism, or reduces an organism’s ability to respond to an additional environmental challenge.”

FDA’s lack of a practical definition for adverse health effect and how the agency applies it in food safety assessments has likely contributed to inconsistencies in its decision making.

Next Steps

We will continue to press the agency for transparency about what health effects it considers important to prevent and protect the health of American families. FDA should publish clear, rational, science-based criteria for determining adverse effects and periodically review them as our knowledge base advances to better inform regulatory decisions.

Posted in Adverse health effects, FDA, Health hazards, Health policy, Health science, Public health, Regulation / Tagged , , , | Authors: , / Comments are closed

European Commission plans to ban food uses of BPA. We ask again: Where is FDA?

Maricel Maffini, consultant, and Tom Neltner, Senior Director, Safer Chemicals

What Happened?

On June 2, the European Commission, the executive body of the European Union (EU) responsible for proposing legislation and implementing decisions, announced it is preparing an initiative that “will impose a ban on the use of BPA [bisphenol A] in food contact materials (FCMs), including plastic and coated packaging.” It also said it would “address the use of other bisphenols in FCMs to avoid replacing BPA with other harmful substances.” The Commission’s proposal is based on the European Food Safety Authority’s (EFSA) scientific opinion that exposure to BPA is a “concern for human health.”

Why It Matters

In April, EFSA concluded that Europeans were exposed to levels of BPA from food that were 100 to 1,000 times greater than the estimated safe amount, and that this exposure could lead to an overactive immune system producing out-of-control inflammation. BPA was also associated with disrupting the endocrine system, harming reproduction, and reducing learning and memory. The immune system was most sensitive to BPA exposure. Recognizing these risks, the Commission moved quickly to protect Europeans’ public health by banning uses of BPA.

Our Take

Americans’ exposure to BPA from food is similar to that in Europe. Unfortunately, FDA doesn’t share the same sense of urgency to protect our families as the European Commission is demonstrating by its actions. While Europe is moving forward to ban the use of BPA in food contact materials, the FDA has failed to take action.

EDF and our allies submitted a food additive petition asking the agency to limit BPA exposure from food by revoking approvals for using BPA in adhesives and can coatings and to setting strict limits on using BPA in plastic that contacts food. FDA filed the petition on May 2, 2022 and has not made a final decision on it despite a 180-day statutory deadline. It is now more than 400 days overdue.

In January, FDA Commissioner Califf announced “a new and transformative vision for the FDA Human Food Programs” which includes a Deputy Commissioner for Human Foods with “decision-making authority over policy, strategy and regulatory program activities.” These are important steps, but a real measure is making timely decisions to protect American’s health by restricting the use of toxic chemicals such as BPA.

Pile of silver metal food cans with no labels

Next Steps

We will continue to press FDA to make a final decision on the petition, including potentially taking legal action for unreasonable delay in responding to our petition.

Posted in BPA, EFSA, Endocrine disruptors, FDA, Food contact materials, Food packaging, Health hazards, Plastic, Public health, Reproductive toxicity / Tagged , , | Authors: , / Comments are closed

Top 10 cities with the most lead pipes

Note: This blog has been updated and adapted. For the most up-to-date information, please visit our new page, Top 10 Cities with the Most Lead Pipes.

 

Roya Alkafaji, Manager, Healthy Communities and Tom Neltner, Senior Director, Safer Chemicals Initiative

EDF identified 10 cities in the U.S. with the most lead service lines (LSLs) based on numbers reported in 2021.[1] These cities collectively have over one million LSLs, representing 12% of the 9.2 million EPA estimates are in the country.

Below we rank each city from most LSLs to fewest, and briefly describe the progress each city has made toward LSL replacement. Some have robust programs, while others have yet to start addressing the problem.

The List

1. Chicago, IL

Chicago Department of Water Management reported 387,095 LSLs in 2021, more than twice as many as the next city on this list. Three-quarters of its service lines are LSLs, and virtually all the rest are of unknown material. City ordinance actually mandated that LSLs be installed until the federal government banned them in 1986.

Decades later, Chicago is struggling to pull itself out of a deep hole relative to most other large cities that took earlier action against lead pipes. Chicago has a small LSL replacement program but applied for a $336 million loan from EPA in 2020[2] and $8 million in state revolving funds (SRF) from Illinois EPA in 2023 to accelerate the effort.

2. Cleveland, OH

Cleveland Water reported 185,409 LSLs in 2021, about 43% of all its service lines.

The utility has a small LSL replacement program but is seeking more than $63 million in federal infrastructure funding from Ohio EPA in 2023 to accelerate the effort.

3. New York, NY

New York City reported 137,542 LSLs in 2021 and an additional 230,870 lines that are of unknown material. About 43% of the city’s service lines are lead or of unknown material.

It has a small LSL replacement program and is seeking more than $58 million in federal infrastructure funding from New York State DEP in 2023 to accelerate the effort.

Read More »

Posted in Drinking water, Lead / Tagged , , , , | Authors: , / Comments are closed

Representatives Call For FDA Public Hearing on Phthalates

By. Joanna Slaney, Senior Director, Federal Affairs, and Maricel Maffini, PhD, Consultant

U.S. Capitol dome framed by trees

Source: A. Paige Baker, ShutterSights.com©

What Happened?

On May 19, Reps. Katie Porter, Steve Cohen, Nanette Diaz Barragán, Earl Blumenauer, and Raúl Grijalva issued a letter [PDF, 300KB] to FDA Commissioner Robert Califf calling on FDA to “act expeditiously to protect the public from the health risks posed by phthalates in food and food packaging.”

They asked the FDA to hold a public hearing on ortho-phthalates (phthalates), chemicals associated with disruptions to the development of the male reproductive system and neurodevelopment, among other health effects.

Why It Matters

In 2021, Reps. Porter and Lieu led a letter with 12 colleagues urging FDA to take action on phthalates in food and cosmetics. That letter, in part, called on FDA to take action on a 2016 petition filed by EDF and allied environmental health organizations asking FDA to revoke its approval for all uses of phthalates in food packaging and processing equipment.

In May 2022, after the petitioners sued, FDA denied the petition. The petitioners formally objected to the decision and requested a public hearing pursuant to FDA’s regulations. The agency has not provided any timeline for acting on the objections.

Request for a Public Hearing

The Representatives stated in the letter submitted last month that  FDA’s decision denying the petition was flawed. “[W]e are deeply concerned about the denial, which was made without deciding whether the remaining approved uses of phthalates in food and food packaging are safe.” (Emphasis original)

They reminded Commissioner Califf of his recent statement that chemical safety is a “really, really important area for the future – for humankind, really – and where science is evolving rapidly,” urging FDA to hold a public hearing on two areas of concern:

  • The agency’s failure to evaluate the safety of phthalates as it was legally required to do before denying the 2016 petition. The letter stated, “failing to evaluate the safety of phthalates is an abdication of the FDA’s continuing obligation to oversee the safety of the food supply.”
  • FDA’s failure to address new toxicity information that raises significant questions about the safety of phthalates. Phthalates are associated with numerous health issues, including reproductive and developmental toxicity, endocrine disruption, immune toxicity, and epigenetic alterations. The letter stated, “the denial of the petition fails to acknowledge, let alone analyze, the dozens of peer-reviewed studies that underscore the toxicity of the phthalates that remain approved for food contact use.”

Next Steps

EDF and our allies will continue to press FDA to hold a public hearing on the safety of phthalates used in food packaging and processing equipment.

Go Deeper

EDF blogs on phthalates

Posted in Congress, Developmental toxicity, Endocrine disruptors, FDA, Food, Food packaging, Health science, Phthalates, Public health, Public hearing, Regulation, Reproductive toxicity / Tagged , , , , , | Authors: , / Comments are closed